CSIMarket
 


Neos Therapeutics Inc   (NEOS)
Other Ticker:  
 

Neos Therapeutics Inc 's Total Debt to Equity

NEOS's quarterly Total Debt to Equity and Total Debt, Equity growth


In III Quarter 2020 Neos Therapeutics Inc had stockholder deficit.

Within Major Pharmaceutical Preparations industry Neos Therapeutics Inc achieved the lowest Total Debt to Equity in the third quarter 2020. While total ranking remained the same in the third quarter 2020 compared to the previous quarter at no. .

Explain Debt to Equity Ratio?
What is the structure of NEOS´s Total Debt?
How valuable is the NEOS´s Equity?


NEOS Total Debt to Equity (Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Total Debt Change 15.3 % -38.06 % -26.77 % -43.8 % -51.95 %
Total Debt to Equity MRQ - - - - -
NEOS's Total Ranking # # # # #
Seq. Equity Change - - - - -
Seq. Total Debt Change 88.1 % -53.55 % 30.56 % 1.08 % 1.05 %



Total Debt to Equity third quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Total Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Neos Therapeutics Inc 's Equity $ -21 Millions Visit NEOS's Balance sheet
Neos Therapeutics Inc 's Total Debt $ 33 Millions Visit NEOS's Balance sheet
Source of NEOS's Sales Visit NEOS's Sales by Geography


Cumulative Neos Therapeutics Inc 's Total Debt to Equity

NEOS's Total Debt to Equity for the trailling 12 Months

NEOS Total Debt to Equity

(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Equity TTM Growth - - - - -
Y / Y Total Debt TTM Growth 15.3 % -38.06 % -26.77 % -43.8 % -51.95 %
Total Debt to Equity TTM - - - - 37.14
Total Ranking TTM
Seq. Equity TTM Growth - - - - -
Seq. Total Debt TTM Growth 88.1 % -53.55 % 30.56 % 1.08 % 1.05 %


On the trailing twelve months basis During the 12 months period ending III Quarter 2020 company had stockholder deficit.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry NEOS recorded the lowest Total Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Debt to Equity Ratio?
What is the structure of NEOS´s Total Debt?
How valuable is the NEOS´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Total Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Total Debt to Equity in the quarter ending Sep 30 2020, within Major Pharmaceutical Preparations Industry Total Debt to EquitySep 30 2020 MRQ Total DebtSep 30 2020 MRQ Equity

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com